What does APOTHEEK PERSYN do?

APOTHEEK PERSYN is a rental company in Oostende. Private Limited, started on 12 September 2006, 1 establishment.

What is the address of APOTHEEK PERSYN?

The registered office of APOTHEEK PERSYN is located at Nieuwpoortsesteenweg 859, 8400 Oostende.

Is APOTHEEK PERSYN still active?

Yes. According to the CBE (31 October 2026) APOTHEEK PERSYN is active, legal situation “Normale toestand”, started on 12 September 2006.

Is APOTHEEK PERSYN registered on Peppol?

Yes, APOTHEEK PERSYN is registered on the Peppol network with ID 0208:0883543207.

What is the enterprise number of APOTHEEK PERSYN?

The enterprise number of APOTHEEK PERSYN is BE0883543207.

When was APOTHEEK PERSYN founded?

APOTHEEK PERSYN was founded on 12 September 2006.

Who are the directors of APOTHEEK PERSYN?

According to the 2025 annual accounts, the directors of APOTHEEK PERSYN are: PERVANTI BV.

Is APOTHEEK PERSYN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 September 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PERSYN make in 2025?

APOTHEEK PERSYN posted a profit after taxes of € 35,750 in financial year 2025.

What is the revenue of APOTHEEK PERSYN?

As a small company, APOTHEEK PERSYN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 59,428.

APOTHEEK PERSYN (Private Limited) - Oostende

Dossier APOTHEEK PERSYN, printed on 31 October 2026 from databakkes.be/en/0883543207/apotheek-persyn. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PERSYN from Oostende, company number BE0883543207, closed financial year 2025 with a result of € 35,750 after tax. For that financial year APOTHEEK PERSYN recorded a gross margin of € 59,428 and equity of € 281,256. Compared with financial year 2024, the result moved from € 32,577 to € 35,750. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Growing

€ 281,256

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 35,750

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,571

▲ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 262,706.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 147,682

▼ 11% vs 2024

€ 18,212 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 1,046

▲ 53% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 944

▲ € 876 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 51,540 Gross margin 2022: € 51,540 First fiscal year in the series	€ 56,581 Gross margin 2023: € 56,581 ▲ 10% vs 2022 (€ 51,540) Favourable step	€ 57,457 Gross margin 2024: € 57,457 ▲ 2% vs 2023 (€ 56,581) Favourable step	€ 59,428 Gross margin 2025: € 59,428 ▲ 3% vs 2024 (€ 57,457) Favourable step	▲ 3%
Profit after taxes	€ 27,148 Profit after taxes 2022: € 27,148 First fiscal year in the series	€ 30,442 Profit after taxes 2023: € 30,442 ▲ 12% vs 2022 (€ 27,148) Favourable step	€ 32,577 Profit after taxes 2024: € 32,577 ▲ 7% vs 2023 (€ 30,442) Favourable step	€ 35,750 Profit after taxes 2025: € 35,750 ▲ 10% vs 2024 (€ 32,577) Favourable step	▲ 10%
Equity	€ 182,487 Equity 2022: € 182,487 First fiscal year in the series	€ 212,929 Equity 2023: € 212,929 ▲ 17% vs 2022 (€ 182,487) Favourable step	€ 245,506 Equity 2024: € 245,506 ▲ 15% vs 2023 (€ 212,929) Favourable step	€ 281,256 Equity 2025: € 281,256 ▲ 15% vs 2024 (€ 245,506) Favourable step	▲ 15%
Total debts	€ 202,523 Total debts 2022: € 202,523 First fiscal year in the series	€ 185,712 Total debts 2023: € 185,712 ▼ 8% vs 2022 (€ 202,523) Favourable step	€ 169,816 Total debts 2024: € 169,816 ▼ 9% vs 2023 (€ 185,712) Favourable step	€ 150,068 Total debts 2025: € 150,068 ▼ 12% vs 2024 (€ 169,816) Favourable step	▼ 12%
Cash	€ 5,595 Cash 2022: € 5,595 First fiscal year in the series	€ 3,570 Cash 2023: € 3,570 ▼ 36% vs 2022 (€ 5,595) Unfavourable step	€ 11,402 Cash 2024: € 11,402 ▲ 219% vs 2023 (€ 3,570) Favourable step	€ 15,571 Cash 2025: € 15,571 ▲ 37% vs 2024 (€ 11,402) Favourable step	▲ 37%
Land & buildings	€ 257,798 Land & buildings 2022: € 257,798 First fiscal year in the series	€ 248,821 Land & buildings 2023: € 248,821 ▼ 3% vs 2022 (€ 257,798) Unchanged	€ 239,843 Land & buildings 2024: € 239,843 ▼ 4% vs 2023 (€ 248,821) Unchanged	€ 231,866 Land & buildings 2025: € 231,866 ▼ 3% vs 2024 (€ 239,843) Unchanged	▼ 3%
Retained profit	€ 163,937 Retained profit 2022: € 163,937 First fiscal year in the series	€ 194,379 Retained profit 2023: € 194,379 ▲ 19% vs 2022 (€ 163,937) Favourable step	€ 226,956 Retained profit 2024: € 226,956 ▲ 17% vs 2023 (€ 194,379) Favourable step	€ 262,706 Retained profit 2025: € 262,706 ▲ 16% vs 2024 (€ 226,956) Favourable step	▲ 16%
Bank debt	€ 197,299 Bank debt 2022: € 197,299 First fiscal year in the series	€ 180,855 Bank debt 2023: € 180,855 ▼ 8% vs 2022 (€ 197,299) Favourable step	€ 165,267 Bank debt 2024: € 165,267 ▼ 9% vs 2023 (€ 180,855) Favourable step	€ 147,682 Bank debt 2025: € 147,682 ▼ 11% vs 2024 (€ 165,267) Favourable step	▼ 11%
Balance sheet total	€ 385,010 Balance sheet total 2022: € 385,010 First fiscal year in the series	€ 398,641 Balance sheet total 2023: € 398,641 ▲ 4% vs 2022 (€ 385,010) Unchanged	€ 415,322 Balance sheet total 2024: € 415,322 ▲ 4% vs 2023 (€ 398,641) Unchanged	€ 431,323 Balance sheet total 2025: € 431,323 ▲ 4% vs 2024 (€ 415,322) Unchanged	▲ 4%

Key figures of APOTHEEK PERSYN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PERSYN?

What happened at APOTHEEK PERSYN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: profit of € 35,750 (▲ 10% vs 2024). Source: NBB ↗
2013 PERVANTI BV became a director. NBB
Sep 20, 2006 New establishment in Oostende. KBO
Sep 12, 2006 Start of the company according to the CBE. KBO

In short

From € 27,148 profit in 2022 to € 35,750 profit in 2025.

Paid € 41,941 in corporate taxes since 2022.

Best year ever: 2025, with € 35,750 profit.

Original PDFs at the National Bank ↗

Management

PERVANTI 75%

The stake of PERVANTI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PERSYN

Behind APOTHEEK PERSYN is PERVANTI BV. The shares are held by PERVANTI (75%).

Directors

According to the 2025 annual accounts

PERVANTI BV

Director · represented by Persyn Ilse

Also active at: APOTHEEK COPPIN

since 2013

Shareholders

PERVANTI

75%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwpoortsesteenweg 859

8400 Oostende

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

COPERVAN

DOKTER T. VANWYNSBERGHE

€ 455,541 gross margin · 2025

PERVANTI same network

€ 228,392 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0883.543.207

VAT number

BE 0883.543.207

Registered office

Nieuwpoortsesteenweg 859, 8400 Oostende

Names & denominations

APOTHEEK PERSYN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 September 2006

Peppol

Active · Active since 5 Jun 2025

Activities · NACE

Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PERSYN

Financials

What happened to APOTHEEK PERSYN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions